Salitrack Pharma ApS
Private limited companyCVR 44952068RødovreActive
Salitrack Pharma ApS is a private limited company, based in Rødovre, active in manufacture of pharmaceutical preparations, founded in 2024. The company is new and has been registered for 2 years. The latest net result (2025) was a loss of DKK 29,451.
Key figures · financial year 2025
Financial statements
Financial years 2025–2025 · amounts in DKK thousand| 2025 | Change | |
|---|---|---|
| Revenue | not stated | – |
| Gross profit | −29 | – |
| Operating profit (EBIT) | −29 | – |
| Profit before tax | −29 | – |
| Net profit | −29 | – |
| Total assets | 134 | – |
| Equity | 11 | – |
| Liabilities | 123 | – |
| Cash and cash equivalents | 134 | – |
| Average number of employees | 0 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLow equity ratio
Equity makes up 8% of total assets in 2025.
How is this calculated?
Equity ÷ total assets is below 10% in the latest annual report. Banks, insurers and some industries naturally have a low ratio.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
1 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 04/07/2024 – 31/12/2025 | 15/06/2026 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Position in the industry
59 companies in the databaseComparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.
Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 64,399of 69,742 Better than 8% | No. 59,477of 69,964 Better than 15% |
| Same industry and fewer than 20 employees37 companies in the comparison | No. 18of 36 Better than 51% | No. 26of 37 Better than 31% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 15,402of 16,614 Better than 7% | No. 12,626of 16,661 Better than 24% |
| All companies of type ApS66,508 companies in the comparison | No. 61,896of 66,379 Better than 7% | No. 55,775of 66,505 Better than 16% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of pharmaceutical preparations- Salitrack Pharma ApS−DKK 29,406
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Salitrack Pharma ApS−DKK 29,451
- Novo Nordisk A/SDKK 102.4bn
- H. Lundbeck A/SDKK 3.2bn
- Salitrack Pharma ApSDKK 10,549
- Novo Nordisk A/SDKK 194bn
- H. Lundbeck A/SDKK 24.9bn
- Salitrack Pharma ApS2
- Novo Nordisk A/S27,279
- H. Lundbeck A/S2,261
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Balwant Rai100%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Balwant Rai | Director | 04/07/2024 |
- Founders
- Balwant Rai
Signing rule: Selskabet tegnes af en direktør.
Address and production units
1 active production unitsAgerskovvej 1A
2610 Rødovre
| Production unit | Address | Employees | P number |
|---|---|---|---|
| SALITRACK PHARMA ApS | Agerskovvej 1A, 1. tv, 2610 Rødovre | 2 | 1030510115 |
Purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
The purpose is quoted from the register in Danish.
Changes year by year
4 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20243 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as SALITRACK PHARMA ApS
- ManagementBalwant Rai appointed director
- OwnershipBalwant Rai registered as owner (100%)
Related companies
Largest in the industry
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Leo Pharma A/SDKK 8.2bn
- Alk-abelló A/SDKK 4.2bn
- Bavarian Nordic A/SDKK 3bn
- Pharmacosmos A/SDKK 1.6bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.